tiprankstipranks
Advertisement
Advertisement

ERAS Stock Latest News

Erasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007
Company AnnouncementsErasca’s HERKULES-3 Trial Reaches Completion: What Investors Should Watch in ERAS-007
12d ago
ERAS
Erasca price target raised to $25 from $24 at JPMorgan
PremiumThe Fly
Erasca price target raised to $25 from $24 at JPMorgan
19d ago
ERAS
Erasca price target raised to $20 from $12 at Guggenheim
PremiumThe Fly
Erasca price target raised to $20 from $12 at Guggenheim
21d ago
ERAS
Erasca price target raised to $18 from $11 at Piper Sandler
PremiumThe Fly
Erasca price target raised to $18 from $11 at Piper Sandler
24d ago
ERAS
Erasca price target raised to $19 from $16 at Mizuho
PremiumThe Fly
Erasca price target raised to $19 from $16 at Mizuho
24d ago
ERAS
Erasca reports Q4 EPS (10c), consensus (11c)
PremiumThe FlyErasca reports Q4 EPS (10c), consensus (11c)
25d ago
ERAS
Erasca: Pan-RAS Data Momentum and Strategic Partnerships Underpin Upsized Revenue Outlook and Buy Rating
Premium
Ratings
Erasca: Pan-RAS Data Momentum and Strategic Partnerships Underpin Upsized Revenue Outlook and Buy Rating
27d ago
ERAS
Erasca price target raised to $20 from $10 at Stifel
Premium
The Fly
Erasca price target raised to $20 from $10 at Stifel
27d ago
ERAS
RVMD
Erasca exercises option to secure worldwide rights for ERAS-0015
PremiumThe Fly
Erasca exercises option to secure worldwide rights for ERAS-0015
27d ago
ERAS
Erasca added to ‘Positive Catalyst Watch list’ at JPMorgan
PremiumThe Fly
Erasca added to ‘Positive Catalyst Watch list’ at JPMorgan
28d ago
ERAS
Compelling Risk‑Reward in Erasca’s RAS/MAPK Pipeline Ahead of Key ERAS-0015 2026 Readout
PremiumRatings
Compelling Risk‑Reward in Erasca’s RAS/MAPK Pipeline Ahead of Key ERAS-0015 2026 Readout
28d ago
ERAS
Tango Therapeutics price target raised to $20 from $18 at Guggenheim
PremiumThe Fly
Tango Therapeutics price target raised to $20 from $18 at Guggenheim
1M ago
ERAS
TNGX
Erasca price target raised to $20 from $11 at Clear Street
PremiumThe FlyErasca price target raised to $20 from $11 at Clear Street
1M ago
ERAS
Midday Fly By: Stocks tumble as oil prices climb again
Premium
The Fly
Midday Fly By: Stocks tumble as oil prices climb again
1M ago
BJ
GO
Erasca, Tango Therapeutics enter clinical collaboration, supply agreement
Premium
The Fly
Erasca, Tango Therapeutics enter clinical collaboration, supply agreement
1M ago
ERAS
TNGX
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
PremiumMarket News
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
1M ago
XBI
ERAS
Erasca announces issuance of U.S. patent covering ERAS-4001
PremiumThe Fly
Erasca announces issuance of U.S. patent covering ERAS-4001
1M ago
ERAS
Erasca extends cash runway after upsized public offering
PremiumCompany Announcements
Erasca extends cash runway after upsized public offering
2M ago
8K
ERAS
Erasca price target raised to $12 from $5 at Guggenheim
PremiumThe Fly
Erasca price target raised to $12 from $5 at Guggenheim
2M ago
ERAS
Erasca assumed with an Outperform at Mizuho
PremiumThe FlyErasca assumed with an Outperform at Mizuho
2M ago
ERAS
Erasca price target raised to $10 from $4 at Morgan Stanley
Premium
The Fly
Erasca price target raised to $10 from $4 at Morgan Stanley
2M ago
ERAS
Erasca Announces Major Underwritten Public Equity Offering
Premium
Company Announcements
Erasca Announces Major Underwritten Public Equity Offering
2M ago
8K
ERAS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >